Novavax Future Growth

Future criteria checks 3/6

Novavax is forecast to grow earnings and revenue by 75.4% and 6.5% per annum respectively while EPS is expected to grow by 79.9% per annum.

Key information

75.4%

Earnings growth rate

79.9%

EPS growth rate

Biotechs earnings growth20.6%
Revenue growth rate6.5%
Future return on equityn/a
Analyst coverage

Good

Last updated20 Mar 2024

Recent future growth updates

Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Mar 01
Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Recent updates

Novavax: Another Day Older And Deeper In

Mar 02

Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Mar 02
Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Mar 01
Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Novavax Q4 Earnings Preview: Settlement With Gavi Doesn't Solve Problems

Feb 23

Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

Sep 06
Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) Outlook

Mar 05
Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) Outlook

COVID-19 remains global health emergency - WHO

Oct 19

Earnings and Revenue Growth Forecasts

NasdaqGS:NVAX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,104172368-373
12/31/20259290-298-1836
12/31/2024850-90-68-2226
12/31/2023984-545-773-714N/A
9/30/20231,050-549-727-655N/A
6/30/20231,597-587-737-654N/A
3/31/20231,359-1,155-753-653N/A
12/31/20221,982-658-509-416N/A
9/30/20221,847-1,322-728-641N/A
6/30/20221,291-1,476-814-744N/A
3/31/20221,403-1,318-489-429N/A
12/31/20211,146-1,744265323N/A
9/30/20211,204-1,075454537N/A
6/30/20211,182-950593672N/A
3/31/2021919-615575644N/A
12/31/2020476-418-97-43N/A
9/30/2020205-2734962N/A
6/30/202050-933237N/A
3/31/202018-115-110-109N/A
12/31/201919-133-138-137N/A
9/30/201916-150-160-158N/A
6/30/201921-177-162-159N/A
3/31/201929-182-171-169N/A
12/31/201834-185-186-185N/A
9/30/201839-186-184-183N/A
6/30/201839-186-196-194N/A
3/31/201835-186-169-166N/A
12/31/201731-184-149-144N/A
9/30/201726-190N/A-162N/A
6/30/201721-212N/A-181N/A
3/31/201717-247N/A-230N/A
12/31/201615-280N/A-259N/A
9/30/201616-302N/A-249N/A
6/30/201619-269N/A-215N/A
3/31/201631-210N/A-165N/A
12/31/201536-157N/A-126N/A
9/30/201537-110N/A-91N/A
6/30/201539-96N/A-78N/A
3/31/201533-94N/A-77N/A
12/31/201431-83N/A-67N/A
9/30/201433-65N/A-60N/A
6/30/201429-61N/A-59N/A
3/31/201425-56N/A-55N/A
12/31/201321-52N/A-45N/A
9/30/201317-46N/A-36N/A
6/30/201318-38N/A-26N/A
3/31/201321-31N/A-25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NVAX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: NVAX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NVAX is expected to become profitable in the next 3 years.

Revenue vs Market: NVAX's revenue (6.5% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: NVAX's revenue (6.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NVAX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.